• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原奈梅亨型:与组织型纤溶酶原激活物(t-PA)介导的纤溶酶原激活受损及t-PA结合减少相关的先天性异常纤维蛋白原血症

Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.

作者信息

Engesser L, Koopman J, de Munk G, Haverkate F, Nováková I, Verheijen J H, Briët E, Brommer E J

机构信息

Gaubius Institute TNO, Leiden, The Netherlands.

出版信息

Thromb Haemost. 1988 Aug 30;60(1):113-20.

PMID:3142089
Abstract

Congenital dysfibrinogenemia was found in a patient with venous thrombosis. Blood clot lysis was prolonged and suggested an impairment of fibrinolysis. We investigated whether this was related to the fibrinogen abnormality. Fibrinopeptide release was normal but fibrin polymerization was defective in the patient. The stimulating effect of the patient's fibrin on t-PA mediated plasminogen activation was impaired. This could not be attributed to defective binding of plasminogen. However, the binding of t-PA to the patient's fibrin was about 16% less than to normal fibrin. A variant t-PA (G K1 K2 P), which contained only one of the two fibrin binding sites, i.e. the kringle-2 domain, was bound to the abnormal fibrin for only 50% of normal. We conclude that the prolongation of blood clot lysis and the impaired stimulation of t-PA mediated plasminogen activation are related to the defective binding of the kringle-2 domain of t-PA onto the fibrin moiety of the abnormal fibrinogen. The impairment of fibrinolysis might explain the occurrence of thrombosis in the patient.

摘要

在一名静脉血栓形成患者中发现了先天性异常纤维蛋白原血症。血凝块溶解时间延长,提示纤溶功能受损。我们研究了这是否与纤维蛋白原异常有关。该患者的纤维蛋白肽释放正常,但纤维蛋白聚合存在缺陷。患者纤维蛋白对组织型纤溶酶原激活物(t-PA)介导的纤溶酶原激活的刺激作用受损。这不能归因于纤溶酶原结合缺陷。然而,t-PA与患者纤维蛋白的结合比与正常纤维蛋白的结合少约16%。一种仅含有两个纤维蛋白结合位点之一即kringle-2结构域的变异型t-PA(G K1 K2 P)与异常纤维蛋白的结合仅为正常情况的50%。我们得出结论,血凝块溶解时间延长以及t-PA介导的纤溶酶原激活刺激受损与t-PA的kringle-2结构域与异常纤维蛋白原的纤维蛋白部分结合缺陷有关。纤溶功能受损可能解释了该患者血栓形成的发生。

相似文献

1
Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.纤维蛋白原奈梅亨型:与组织型纤溶酶原激活物(t-PA)介导的纤溶酶原激活受损及t-PA结合减少相关的先天性异常纤维蛋白原血症
Thromb Haemost. 1988 Aug 30;60(1):113-20.
2
The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.纤维蛋白原比塞特尔II(γ亚基天冬酰胺308突变为赖氨酸)的突变不影响组织型纤溶酶原激活物(t-PA)和纤溶酶原与纤维蛋白的结合。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):679-87.
3
Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.异常纤维蛋白原血症(杜萨尔纤维蛋白原)与纤维蛋白增强的纤溶酶原激活受损有关。
Thromb Haemost. 1984 Feb 28;51(1):108-9.
4
Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.可溶性纤维蛋白降解产物增强组织型纤溶酶原激活物诱导的纤维蛋白原蛋白水解作用。
J Clin Invest. 1991 Mar;87(3):1082-90. doi: 10.1172/JCI115069.
5
Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.纤维蛋白原米兰II型:一种与青少年动静脉血栓形成相关的先天性异常纤维蛋白原血症。
Thromb Haemost. 1986 Feb 28;55(1):131-5.
6
Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.纤维蛋白原加拉加斯V型,一种异常纤维蛋白原,具有与血栓形成相关的Aα532丝氨酸至半胱氨酸替换。
Thromb Haemost. 2000 Aug;84(2):263-70.
7
Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).对从杂合性异常纤维蛋白原血症BbetaGly15Cys(滨松II型)中纯化的血浆纤维蛋白原的纤溶酶生成和凝块溶解进行分析。
Blood Coagul Fibrinolysis. 2009 Dec;20(8):726-32. doi: 10.1097/MBC.0b013e328332aa09.
8
Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.组织型纤溶酶原激活剂(t-PA)及其缺失突变体的动力学特性
Thromb Haemost. 1991 Mar 4;65(3):280-5.
9
The role of the finger domain of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in initiation and progression of thrombolysis.
Thromb Haemost. 1994 Dec;72(6):900-5.
10
In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.使用来自γAsn319、Asp320缺失异常纤维蛋白原的杂合血浆纤维蛋白原进行体外纤维蛋白凝块形成和纤维蛋白溶解,大津I。
Thromb Res. 2006;118(5):651-61. doi: 10.1016/j.thromres.2005.10.013. Epub 2006 Jan 10.

引用本文的文献

1
The thrombotic paradox in congenital fibrinogen deficiencies: from pathophysiology to practice.先天性纤维蛋白原缺乏症中的血栓形成悖论:从病理生理学到临床实践
Res Pract Thromb Haemost. 2025 Jul 22;9(5):102979. doi: 10.1016/j.rpth.2025.102979. eCollection 2025 Jul.
2
[Analysis of a family with congenital hypodysfibrinogenemia presented with thrombosis].[一例以血栓形成表现的先天性低纤维蛋白原血症家系分析]
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):865-869. doi: 10.3760/cma.j.issn.0253-2727.2022.10.012.
3
Abnormal fibrinogen with an Aα 16Arg → Cys substitution is associated with multiple cerebral infarctions.
异常纤维蛋白原,其 Aα 16Arg→Cys 取代与多发性脑梗死有关。
J Thromb Thrombolysis. 2018 Oct;46(3):409-419. doi: 10.1007/s11239-018-1689-z.
4
Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders.人纤维蛋白原:先天性疾病的分子和遗传方面。
Int J Mol Sci. 2018 May 29;19(6):1597. doi: 10.3390/ijms19061597.
5
Thrombosis in Inherited Fibrinogen Disorders.遗传性纤维蛋白原异常中的血栓形成
Transfus Med Hemother. 2017 Apr;44(2):70-76. doi: 10.1159/000452864. Epub 2017 Mar 14.
6
Fibrinogen, red blood cells, and factor XIII in venous thrombosis.静脉血栓形成中的纤维蛋白原、红细胞和因子 XIII
J Thromb Haemost. 2015 Jun;13 Suppl 1(Suppl 1):S208-15. doi: 10.1111/jth.12918.
7
Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.利马纤维蛋白原:一种纯合子异常纤维蛋白原,具有Aα-精氨酸141至丝氨酸的替换,与Aα-天冬酰胺139处额外的N-糖基化相关。纤维蛋白凝胶形成受损,但组织型纤溶酶原激活剂催化的纤维蛋白促进的纤溶酶原激活正常。
J Clin Invest. 1992 Jul;90(1):67-76. doi: 10.1172/JCI115857.
8
Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.与凝血酶结合缺陷及血栓形成倾向相关的那不勒斯纤维蛋白原的分子基础。Bβ68位丙氨酸纯合性替代为苏氨酸。
J Clin Invest. 1992 Jul;90(1):238-44. doi: 10.1172/JCI115841.
9
Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.异常纤维蛋白原艾默伊登型(Bβ链精氨酸14位至半胱氨酸)和奈梅亨型(Bβ链精氨酸44位至半胱氨酸)形成二硫键连接的纤维蛋白原 - 白蛋白复合物。
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3478-82. doi: 10.1073/pnas.89.8.3478.